✦ LIBER ✦

A 4-Year Longitudinal Study of 555 Patients Treated with Ranibizumab for Neovascular Age-related Macular Degeneration

✍ Scribed by Rasmussen, Annette; Bloch, Sara B.; Fuchs, Josefine; Hansen, Louise H.; Larsen, Michael; LaCour, Morten; Lund-Andersen, Henrik; Sander, Birgit

Book ID: 120831558
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 390 KB
Volume: 120
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2013.05.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measuring the benefit of 4 years of intr

Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration

✍ Pushpoth, S.; Sykakis, E.; Merchant, K.; Browning, A. C.; Gupta, R.; Talks, S. J 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 161 KB

Randomized, Double-Masked, Sham-Controll

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

✍ Carl D. Regillo; David M. Brown; Prema Abraham; Huibin Yue; Tsontcho Ianchulev; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 856 KB

Ranibizumab versus Verteporfin Photodyna

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

✍ David M. Brown; Mark Michels; Peter K. Kaiser; Jeffrey S. Heier; Judy P. Sy; Tso 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Four-Year Treatment Results of Neovascul

Four-Year Treatment Results of Neovascular Age-Related Macular Degeneration With Ranibizumab and Causes for Discontinuation of Treatment

✍ Mads Krüger Falk; Henrik Kemp; Torben Lykke Sørensen 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Clinical course of patients with exudati

Clinical course of patients with exudative-haemorrhagic age-related macular degeneration treated with ranibizumab. Eye2Eye study

✍ Araiz, J.; Fernández-Baca, I.; Roura, M. 📂 Article 📅 2013 🏛 Elsevier ⚖ 593 KB

Ranibizumab for Treatment of Neovascular

Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: A Phase I/II Multicenter, Controlled, Multidose Study

✍ Jeffrey S. Heier; Andrew N. Antoszyk; Peter Reed Pavan; Steven R. Leff; Philip J 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 311 KB